New perspectives in treating high-risk cardiac patients. Rosuvastain and it’s perspectives for clinical practice use
The review summarizes modern principles of lipid-lowering therapy aimed at cardiovascular event risk reduction. The author describes main patient groups in need for early, aggressive lipid-lowering therapy – predominantly, statin therapy. New statin treatment tactics is presented, based on the lates...
| Main Author: | |
|---|---|
| Format: | Article |
| Language: | Russian |
| Published: |
«SILICEA-POLIGRAF» LLC
2007-12-01
|
| Series: | Кардиоваскулярная терапия и профилактика |
| Subjects: | |
| Online Access: | https://cardiovascular.elpub.ru/jour/article/view/1419 |
| _version_ | 1827064113188044800 |
|---|---|
| author | M. G. Bubnova |
| author_facet | M. G. Bubnova |
| author_sort | M. G. Bubnova |
| collection | DOAJ |
| description | The review summarizes modern principles of lipid-lowering therapy aimed at cardiovascular event risk reduction. The author describes main patient groups in need for early, aggressive lipid-lowering therapy – predominantly, statin therapy. New statin treatment tactics is presented, based on the latest results of recent large-scale clinical trials. The article also contains the results of clinical trials on a new generation statin, rosuvastatin, its lipid-lowering and anti-atherosclerotic effects, its pharmacological features and clinical use perspectives. |
| first_indexed | 2024-04-10T03:39:50Z |
| format | Article |
| id | doaj.art-bea8a0e23ae941d897cf99c484e787bd |
| institution | Directory Open Access Journal |
| issn | 1728-8800 2619-0125 |
| language | Russian |
| last_indexed | 2025-03-19T22:41:59Z |
| publishDate | 2007-12-01 |
| publisher | «SILICEA-POLIGRAF» LLC |
| record_format | Article |
| series | Кардиоваскулярная терапия и профилактика |
| spelling | doaj.art-bea8a0e23ae941d897cf99c484e787bd2024-10-17T12:21:25Zrus«SILICEA-POLIGRAF» LLCКардиоваскулярная терапия и профилактика1728-88002619-01252007-12-016675821129New perspectives in treating high-risk cardiac patients. Rosuvastain and it’s perspectives for clinical practice useM. G. Bubnova0State Research Center for Preventive Medicine, Federal Agency on High Medical Technologies; I.M. Sechenov Moscow Medical Academy, MoscowThe review summarizes modern principles of lipid-lowering therapy aimed at cardiovascular event risk reduction. The author describes main patient groups in need for early, aggressive lipid-lowering therapy – predominantly, statin therapy. New statin treatment tactics is presented, based on the latest results of recent large-scale clinical trials. The article also contains the results of clinical trials on a new generation statin, rosuvastatin, its lipid-lowering and anti-atherosclerotic effects, its pharmacological features and clinical use perspectives.https://cardiovascular.elpub.ru/jour/article/view/1419lipid-lowering therapystatinsrosuvastatinhigh risklow-density lipoprotein cholesteroltarget levels |
| spellingShingle | M. G. Bubnova New perspectives in treating high-risk cardiac patients. Rosuvastain and it’s perspectives for clinical practice use Кардиоваскулярная терапия и профилактика lipid-lowering therapy statins rosuvastatin high risk low-density lipoprotein cholesterol target levels |
| title | New perspectives in treating high-risk cardiac patients. Rosuvastain and it’s perspectives for clinical practice use |
| title_full | New perspectives in treating high-risk cardiac patients. Rosuvastain and it’s perspectives for clinical practice use |
| title_fullStr | New perspectives in treating high-risk cardiac patients. Rosuvastain and it’s perspectives for clinical practice use |
| title_full_unstemmed | New perspectives in treating high-risk cardiac patients. Rosuvastain and it’s perspectives for clinical practice use |
| title_short | New perspectives in treating high-risk cardiac patients. Rosuvastain and it’s perspectives for clinical practice use |
| title_sort | new perspectives in treating high risk cardiac patients rosuvastain and it s perspectives for clinical practice use |
| topic | lipid-lowering therapy statins rosuvastatin high risk low-density lipoprotein cholesterol target levels |
| url | https://cardiovascular.elpub.ru/jour/article/view/1419 |
| work_keys_str_mv | AT mgbubnova newperspectivesintreatinghighriskcardiacpatientsrosuvastainanditsperspectivesforclinicalpracticeuse |